🇯🇵 Carac in Japan

PMDA authorised Carac on 21 September 2018

Marketing authorisation

PMDA — authorised 21 September 2018

  • Marketing authorisation holder: Kyowa Hakko Kirin Co., Ltd.
  • Status: approved

Carac in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Carac approved in Japan?

Yes. PMDA authorised it on 21 September 2018.

Who is the marketing authorisation holder for Carac in Japan?

Kyowa Hakko Kirin Co., Ltd. holds the Japanese marketing authorisation.